loader image
Friday, September 5, 2025
95.8 F
McAllen
- Advertisement -

Miller School Researcher Publishes Breakthrough Findings on Nanoparticle Delivery of HIV/AIDS Medications to Brain

Translate to Spanish or other 102 languages!

Newswise Images

Mega Doctor News

- Advertisement -

by University of Miami Health System, Miller School of Medicine 

Newswise — A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems. 

“While HIV can be managed as a chronic condition, current drugs cannot cross the blood-brain barrier,” said Shanta Dhar, Ph.D., associate professor of biochemistry and molecular biology, and assistant director of technology and innovation at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. “Therefore, the ability of nanoparticles to deliver antiretroviral drugs to the brain is a significant breakthrough that could potentially improve the treatment of brain cancers and other diseases.” 

- Advertisement -

 For the past decade, Dr. Dhar has been studying a polymer chain nanoparticle as a vehicle for intracellular drug delivery. Her latest laboratory study, “Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress,” was published recently in the American Chemical Society journal, ACS Nano.  

Miller School co-authors were Bapurao Surnar, Ph.D; Anuj S. Shah; Minseon Park,  Ph.D; Akil A. Kalathil; Mohammad Z. Kamra, Ph.D.; and Michal Toborek, M.D., Ph.D. The research team included Nagesh Kolishetti, Ph.D., as a corresponding author; his student, Royden Ramirez Jaime; and Madhavan Nair, Ph.D.; all from the Herbert Wertheim College of Medicine, Florida International University. 

Drs. Dhar and Kolishetti said, “Using an experimental model, we were able to use biodegradable brain-targeted polymeric nanoparticles to reduce the HIV/AIDS viral burden. We also included antioxidant and anti-inflammatory neuroprotectants to address stress and inflammation in the brain cells.”  

Dr. Dhar noted that nanoparticle drug delivery offers a new strategy for treating HIV-associated neurocognitive disorders, such as HIV dementia, which can be magnified by recreational drug use in HIV-positive individuals. She added, “Looking ahead, this therapeutic strategy, which we have demonstrated in our laboratory, has great potential for improving treatment of a wide range of brain diseases.” 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Rio Grande Valley College Celebrates Graduation of 2nd Cohort of RN Apprentices, in Partnership with DHR Health

Mega Doctor News Pharr, Texas - Patient care is being enhanced, thanks to...

Tips for Spotting Concussions in Student Athletes

Mega Doctor News CLEVELAND CLINIC - Young athletes aren’t always quick to...

Fall Prevention Education Series for Seniors & Caregivers Launched

Mega Doctor News It’s a simple fact: As you age, your risk of falling significantly increases. It’s...

Dutch Bros Bucks for Kids Day, September 19th

Mega Doctor News A hospital setting can prove to be a frightening and...
- Advertisement -
×